Related Experiment Video
Updated: May 9, 2026
07:32
Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
Published on: March 19, 2015
Iron acquisition in the human fungal pathogen Cryptococcus neoformans
1Department of Systems Biotechnology, Chung-Ang University, Anseong 456-756, Republic of Korea.
Current Opinion in Microbiology
|August 10, 2013
Summary
Pathogenic microbes like Cryptococcus neoformans use iron acquisition systems to overcome host nutritional immunity. This review details C. neoformans
Area of Science:
- Microbiology
- Mycology
- Immunology
Background:
- Vertebrate hosts employ nutritional immunity, sequestering iron to inhibit microbial pathogens.
- Pathogenic microbes evolve sophisticated iron acquisition systems to counteract nutritional immunity.
- Cryptococcus neoformans, a fungal pathogen, requires iron for survival and virulence in hosts.
Purpose of the Study:
- To review current knowledge on iron acquisition systems in Cryptococcus neoformans.
- To identify key components and regulatory elements involved in fungal iron uptake.
- To understand how pathogen localization influences iron acquisition strategies.
Main Methods:
- Literature review of existing studies on Cryptococcus neoformans iron metabolism.
- Analysis of genetic and molecular mechanisms underlying iron acquisition.
- Synthesis of findings on host-pathogen interactions related to iron.
Main Results:
- Cryptococcus neoformans utilizes multiple iron sources within the vertebrate host.
- Distinct iron acquisition strategies are employed based on the fungus's location (intracellular vs. extracellular).
- Key components and regulatory networks governing iron uptake have been identified.
Conclusions:
- Iron acquisition is critical for Cryptococcus neoformans pathogenesis.
- Understanding these systems offers potential targets for therapeutic intervention.
- Further research is needed to fully elucidate the complexity of fungal iron acquisition.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...